519 filings
ARS
2023 FY
ALDX
Aldeyra Therapeutics Inc
22 Apr 24
Annual report to shareholders
4:18pm
DEFA14A
ALDX
Aldeyra Therapeutics Inc
22 Apr 24
Additional proxy soliciting materials
4:13pm
DEF 14A
ALDX
Aldeyra Therapeutics Inc
Definitive proxy
22 Apr 24
4:11pm
4/A
Stephen Machatha
17 Apr 24
Aldeyra Therapeutics / Stephen Machatha ownership change
4:12pm
4/A
Bruce Greenberg
17 Apr 24
Aldeyra Therapeutics / Bruce Greenberg ownership change
4:10pm
4
ALDX
Aldeyra Therapeutics Inc
8 Apr 24
Aldeyra Therapeutics / JOSEPH EDELMAN ownership change
5:32pm
4
ALDX
Aldeyra Therapeutics Inc
3 Apr 24
Aldeyra Therapeutics / JOSEPH EDELMAN ownership change
5:22pm
8-K
ALDX
Aldeyra Therapeutics Inc
28 Mar 24
Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease
7:01am
4
Bruce Greenberg
12 Mar 24
Aldeyra Therapeutics / Bruce Greenberg ownership change
8:07pm
4
ALDX
Aldeyra Therapeutics Inc
12 Mar 24
Aldeyra Therapeutics / Stephen Machatha ownership change
8:04pm
4
Todd C Brady
12 Mar 24
Aldeyra Therapeutics / Todd C Brady ownership change
8:01pm
144
ALDX
Aldeyra Therapeutics Inc
12 Mar 24
Notice of proposed sale of securities
4:03pm
144
Bruce Greenberg
11 Mar 24
Notice of proposed sale of securities
9:11pm
144
Stephen Machatha
11 Mar 24
Notice of proposed sale of securities
8:43pm
144
Todd C Brady
11 Mar 24
Notice of proposed sale of securities
7:12pm
S-3
ALDX
Aldeyra Therapeutics Inc
Shelf registration
7 Mar 24
4:54pm
S-8
ALDX
Aldeyra Therapeutics Inc
7 Mar 24
Registration of securities for employees
4:48pm
S-8 POS
ALDX
Aldeyra Therapeutics Inc
7 Mar 24
Registration of securities for employees (post-effective amendment)
4:40pm
10-K
2023 FY
ALDX
Aldeyra Therapeutics Inc
Annual report
7 Mar 24
4:06pm
SC 13G/A
ALDX
Aldeyra Therapeutics Inc
14 Feb 24
Aldeyra Therapeutics / PERCEPTIVE ADVISORS ownership change
4:52pm